NanoString announced new GeoMx COVID-19 Consortium, part of the GeoMx Translational Leadership Network
Biology, Biotechnology, COVID-19, Diagnostics, Disease, Infectious Disease, Life Science News, Oncology, Therapeutics
On Sept. 9, 2020, NanoString Technologies announced the formation of the GeoMx Translational Leadership Network (GTLN). The GTLN will pioneer the application of spatial biology in large translational research studies, developing and sharing standardized practices to facilitate collaboration between groups of researchers across multiple institutions.
To date, the GTLN included members of the GeoMx Breast Cancer Consortium, established in 2019, and the newly established GeoMx COVID-19 Consortium.
Tags:
Source: NanoString Technologies
Credit: